Table 2.
MEN N = 2,007 | WOMEN N = 4,380 | |||||||
---|---|---|---|---|---|---|---|---|
Indicator markers |
Prevalence of marker |
Interval |
Prevalence of marker |
Interval |
||||
(days before RA code) |
(days before RA code) |
|||||||
|
N |
% |
Median |
IQR |
N |
% |
Median |
[IQR] |
Inflammatory arthritis diagnosis |
237 |
11.8 |
79 |
[22–154] |
469 |
10.7 |
71 |
[17–175] |
Synovitis |
65 |
3.2 |
66 |
[22–153] |
114 |
2.6 |
84 |
[28–188] |
RhF test |
1,114 |
55.5 |
49 |
[9–137] |
2,397 |
54.7 |
43 |
[6–127] |
DMARD prescription (not including steroids) |
681 |
33.9 |
45 |
[0–309] |
1353 |
30.9 |
71 |
[0–326] |
Referral to Rheum |
811 |
40.4 |
66 |
[13–183] |
1642 |
37.5 |
70 |
[11–193] |
Joint sign or symptom |
1032 |
51.4 |
132 |
[54.5-245] |
2202 |
50.3 |
133.5 |
[52–259] |
Keywords |
Prevalence of keyword |
Interval |
Prevalence of keyword |
Interval |
||||
(days before RA code) |
(days before RA code ) |
|||||||
|
N |
% |
Median |
IQR |
N |
% |
Median |
IQR |
Rheumatoid A |
590 |
29.4 |
37 |
[0–121] |
1,262 |
28.8 |
28 |
[0–122] |
Positive RhF test |
911 |
45.4 |
49 |
[7–136] |
2,033 |
46.4 |
47 |
[7–151] |
Inflammatory arthritis |
378 |
18.8 |
70 |
[17–168] |
790 |
18.0 |
78 |
[21–183] |
Synovitis | 379 | 18.9 | 57 | [7–159] | 789 | 18.0 | 55 | [7–160] |